• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.261.3-262
• /
• 2002

The herbal combination allergina has been used for the treatment of inflammatory diseases in South Korea. In this study. we investigated the immunosuppressive activities of allergina in more detail. Acute graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in patients undergoing allogeneic bone marrow transplantation. (omitted)

• Archives of Pharmacal Research
• /
• 제26권4호
• /
• pp.312-316
• /
• 2003

The oriental herbal combination allergina has been shown to inhibit allergic inflammation. In the present study, we demonstrate that the oral administration of allergina markedly inhibits the progression of inflammatory diseases, such as graft-versus-host diseases (in the allogeneic bone marrow transplantation and the parent-into-F1 transplantation models), collagen-induced arthritis and sheep red blood cell-induced delayed type hypersensitivity. The immunosuppressive activity of allergina in vivo appears to be associated, at least in part, with the inhibition of tumor necrosis factor-a production. In conclusion, our results suggest that allergina could be useful as a immunosuppressive agent for the treatment of macrophage-related inflammatory disease.

• Natural Product Sciences
• /
• 제26권1호
• /
• pp.59-63
• /
• 2020

This study focused on investigation of the immunosuppressive inhibitory effect through determination of IL-2 production of nine compounds (1 - 9) isolated from Chlamydomonas sp. KSF108. Among them, compounds 1, 5, and 6 displayed moderately inhibitory effects on IL-2 production at a concentration of 100 µM. In addition, the related ones including cytotoxic, anti-inflammatory, and anti-oxidant activities were also elucidated. 6 further displayed cytotoxic activity against the MCF-7 cell line, with an IC₅₀ value of 17.2 µM and 4, 6 - 7, and 9 possessed significant DPPH radical scavenging activity, with IC₅₀ values ranging from 3.1 to 4.4 µM. To the best of our knowledge, this is the first report on the bioactivity of isolated chemical constituents from the genus Chlamydomonas. Compounds 1 and 5 investigated for the first time in the activity of immunosuppressivity and 6 may come to serve as the most important marker in broad-spectrum activities of the secondary metabolites identified from C. sp. KSF108.

• Biomolecules & Therapeutics
• /
• 제20권1호
• /
• pp.19-26
• /
• 2012

There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. Encouraged by natural cyclic peptides with biological activity, efforts have been made to develop cyclic peptides with both genetic and synthetic methods. The genetic methods include phage display, intein-based cyclic peptides, and mRNA display. The synthetic methods involve individual synthesis, parallel synthesis, as well as split-and-pool synthesis. Recent development of cyclic peptide library based on split-and-pool synthesis allows on-bead screening, in-solution screening, and microarray screening of cyclic peptides for biological activity. Cyclic peptides will be useful as receptor agonist/antagonist, RNA binding molecule, enzyme inhibitor and so on, and more cyclic peptides will emerge as therapeutic agents and biochemical tools.

• 한국응용곤충학회지
• /
• 제51권3호
• /
• pp.245-253
• /
• 2012

벤질리덴아세톤(benzylinedeneacetone: BZA)은 두 곤충병원세균인 Xenorhabdus nematophila와 Photorhabdus temperata subsp. temperata에서 유래된 대사산물의 일종이다. 이 물질은 곤충의 세포성 및 체액성 면역반응을 억제하며 또한 다양한 세균이나 곰팡이에 대해 항생효과를 갖고 있다. 그러나 이 물질이 갖는 비교적 높은 약해와 낮은 식물체 침투력은 효과적 농약으로 개발하는 데 어려움을 주고 있다. 본 연구에서는 다섯 개의 서로 다른 BZA 유사체를 스크리닝하여 면역억제 및 항균활성을 유지하면서 비교적 용해도가 높고 약해가 낮은 물질을 선발하였다. BZA의 벤젠 고리에 수산기가 붙은 유도체는 면역억제 및 항균활성이 뚜렷이 낮아졌다. 또한 BZA의 케톤기를 카르복실기로 변형하면 면역억제와 항균활성을 잃게 되었다. 그러나 BZA의 탄화수소 사슬을 짧게 하여 형성된 아세테이트 유도체인 4-hydroxyphenylacetic acid (HPA)는 면역억제와 항균활성을 잃지 않았다. 또한 HPA는 BZA 보다 고추(Capsicum annuum)에 대해 약해가 낮은 것으로 나타났다. 이 연구는 낮은 약해를 유발하면서 높은 곤충면역억제와 식물병원균에 대해 높은 항균활성을 보이는 BZA 유도체를 선발하였다.

• 디지털융복합연구
• /
• 제13권6호
• /
• pp.235-246
• /
• 2015

신장이식 후 면역억제제 투약 이행은 신장이식 대상자의 생존율과 삶의 질을 높이는데 필수적인 요소이며, 대상자의 심리사회적 특성이나 치료지침에 대한 태도에 따라 달라질 수 있다. 투약이행 증진을 위해 대상자는 열린 마음으로 필요한 정보를 학습하는 융복합적 태도를 가질 필요가 있다. 신장이식 대상자의 면역억제제 투약 이행에 대한 태도를 알아보기 위해 Q 방법론을 이용하여 면역억제제 투약 이행에 대한 태도 유형과 유형별 특성을 확인하였다. 수집된 자료는 PC QUANL 프로그램에 의한 주인자분석법으로 처리하였다. 신장이식 대상자의 면역억제제 투약이행에 대한 태도는 '긍정적 생활관리형(n=15)', '조마조마한 외모관리형(n=11)', '침울한 망각형(n=7)', '방심하지 않는 가족지지형(n=7)'의 네 가지 유형으로 확인되었다. 신장이식 후 대상자의 면역억제제 투약 이행에 대한 태도의 확인을 통해 반복적이고 개별화된 신장이식 후 면역억제제 투약관리 프로그램의 필요성을 확인할 수 있었다.

• Journal of Microbiology and Biotechnology
• /
• 제27권6호
• /
• pp.1189-1197
• /
• 2017

Lichen-forming fungi are known to have various biological activities, such as antioxidant, antimicrobial, antitumor, antiviral, anti-inflammation, and anti proliferative effects. However, the immunosuppressive effects of Bryoria sp. extract (BSE) have not previously been investigated. In this study, the inhibitory activity of BSE on the proliferation of $CD8^+$ T cells and the mixed lymphocytes reaction (MLR) was evaluated in vitro. BSE was non-toxic in spleen cells and suppressed the growth of splenocytes induced by anti-CD3. The suppressed cell population in spleen cells consisted of $CD8^+$ T cells and their proliferation was inhibited by the treatment with BSE. This extract significantly suppressed the IL-2 associated with T cell growth and $IFN-{\gamma}$ as the $CD8^+$ T cell marker. Furthermore, BSE reduced the expression of the IL-2 receptor alpha chain ($IL-2R{\alpha}$) on $CD8^+$ T cells and CD86 on dendritic cells by acting as antigen-presenting cells. Finally, the MLR produced by the co-culture of C57BL/6 and MMC-treated BALB/c was suppressed by BSE. IL-2, $IFN-{\gamma}$, and CD69 on $CD8^+$ T cells in MLR condition were inhibited by BSE. These results indicate that BSE inhibits the MLR via the suppression of $IL-2R{\alpha}$ expression in $CD8^+$ T cells. BSE has the potential to be developed as an anti-immunosuppression agent for organ transplants.

• Archives of Pharmacal Research
• /
• 제15권2호
• /
• pp.169-175
• /
• 1992

Anti-inflammatory glucocorticoid (GC) derivatives have been clinically used in immune-malfunctional diseases for their immunosuppressive activity. However, there is still a lack of knowledge on the relationship between anti-inflammatory and immunosuppressive activities. In order to compare immunosuppressive activities with the known anti-inflammatory activities of the GC derivatives, eight clinically used GC derivatives including hydrocortisone, prednislone, 6$\alpha$-methyl prednisolone, triamcinolone, dexamethasone, betamethasone, triamcinolone acetonide and fluocinolone acetonide were selected, and lymphoblastosis inhibition and plaque-forming cell (PFC) response in mice were studied as immunological parameters. In Con A-induced lymphoblatosis inhibition invitro, all derivatives showed potent inhibition $IC_{50}$ values of the derivaties except methyl prednisolone and triamcinolone were less than $10^{-7}$M and good dose dependency was obtained. This result was well correlated with that of their anti-inflammatory potencies obtained. This result was well correlated with that of their anti-inflammatory potencies and their receptor binding affinities. However, in PFC response, consistent result were not obtained. Total numbers of PFCs per spleen were decreased by some derivatives, but numbers of PFCs per $10^6$ cells were not decreased by systemic administration of but numbers of PFCs per $10^6$ cells were not decreased by systemic administration of GC at the dose of 0.05 mg/mouse. Furthermore, at the dose of 0.1 mg/mouse, numbers of PFCs per $10^6$ cells were found to be increased, although total PFCs per spleen were decreased.

• BMB Reports
• /
• 제43권4호
• /
• pp.279-283
• /
• 2010

Polydnavirus genome is segmented and dispersed on host wasp chromosome. After replication, the segments form double- stranded circular DNAs and embedded in viral coat proteins. These viral particles are delivered into a parasitized host along with parasitoid eggs. A serine-rich protein (SRP) is predicted in a polydnavirus, Cotesia plutellae bracovirus (CpBV), genome in its segment no. 33 (CpBV-S33), creating CpBV-SRP1. This study explored its expression and physiological function in the diamondback moth, Plutella xylostella, larvae parasitized by C. plutellae. CpBV-SRP1 encodes 122 amino acids with 26 serines and several predicted phosphorylation sites. It is persistently expressed in all tested tissues of parasitized P. xylostella including hemocyte, fat body, and gut. Its physiological function was analyzed by injecting CpBV-S33 and inducing its expression in nonparasitized P. xylostella by a technique called SERI (segment expression and RNA interference). The expression of CpBV-SRP1 significantly impaired the spreading behavior and total cell count of hemocytes of treated larvae. Subsequent RNA interference of CpBV-SRP1 rescued the immunosuppressive response. This study reports the persistent expression of CpBV-SRP1 in a parasitized host and its parasitic role in suppressing the host immune response by altering hemocyte behavior and survival.

• Radiation Oncology Journal
• /
• 제38권1호
• /
• pp.1-10
• /
• 2020

Radiotherapy (RT) has been used for decades as one of the main treatment modalities for cancer patients. The therapeutic effect of RT has been primarily ascribed to DNA damage leading to tumor cell death. Besides direct tumoricidal effect, RT affects antitumor responses through immune-mediated mechanism, which provides a rationale for combining RT and immunotherapy for cancer treatment. Thus far, for the combined treatment with RT, numerous studies have focused on the immune checkpoint inhibitors and have shown promising results. However, treatment resistance is still common, and one of the main resistance mechanisms is thought to be due to the immunosuppressive tumor microenvironment where myeloid-derived suppressor cells (MDSCs) play a crucial role. MDSCs are immature myeloid cells with a strong immunosuppressive activity. MDSC frequency is correlated with tumor progression, recurrence, negative clinical outcome, and reduced efficacy of immunotherapy. Therefore, increasing efforts to target MDSCs have been made to overcome the resistance in cancer treatments. In this review, we focus on the role of MDSCs in RT and highlight growing evidence for targeting MDSCs in combination with RT to improve cancer treatment.